Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ahmad Noei"'
Autor:
Amirhosein Maali, Shahriyar Abdoli, Mahdi Habibi-Anbouhi, Ahmad Noei, Maryam Kadkhodazadeh, Mahdieh Motamedirad, Arash Arashkia, Zahra Sharifzadeh
Publikováno v:
Cell Journal, Vol 26, Iss 8, Pp 487-495 (2024)
Objective: CD22, as a surface protein of B cells, is used in the diagnosis and target-specific immunotherapy of B-cellmalignancies. SpyTag and SpyCatcher, on the other hand, are two covalently coupled proteins capable of developinga bi- or multi-spec
Externí odkaz:
https://doaj.org/article/ea88165a54bb43b9b785f225dccaeb17
Autor:
Shafieeh Mansoori, Ahmad Noei, Amirhosein Maali, Seyedeh Sheila Seyed-Motahari, Zahra Sharifzadeh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-22 (2024)
Abstract CAR-T cell therapy is known as an effective therapy in patients with hematological malignancies. Since 2017, several autologous CAR-T cell (auto-CAR-T) drugs have been approved by the US Food and Drug Administration (FDA) for the treatment o
Externí odkaz:
https://doaj.org/article/8699bf73261d447d9122bc152fd6efde
Autor:
Amirhosein Maali, Monireh Gholizadeh, Saba Feghhi-Najafabadi, Ahmad Noei, Seyedeh Sheila Seyed-Motahari, Shafieeh Mansoori, Zahra Sharifzadeh
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The immune system is essential in recognizing and eliminating tumor cells. The unique characteristics of the tumor microenvironment (TME), such as heterogeneity, reduced blood flow, hypoxia, and acidity, can reduce the efficacy of cell-mediated immun
Externí odkaz:
https://doaj.org/article/295b0efdab16476fb6f36333eba73af6
Publikováno v:
Drug Research. 69:144-150
Backgrounds Peptide-based drugs have shown promising results in overcoming the limitations of chemotherapeutic drugs by providing a targeted therapy approach to cancer. However, the response rate of targeted therapies is limited, in large part due to